OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A new generation of AD biomarkers: 2019 to 2021
Jade I. Hawksworth, Esperanza Fernández, Kris Gevaert
Ageing Research Reviews (2022) Vol. 79, pp. 101654-101654
Closed Access | Times Cited: 24

Showing 24 citing articles:

Differential proteomic profile of lumbar and ventricular cerebrospinal fluid
Nina Rostgaard, Markus Harboe Olsen, Maud Eline Ottenheijm, et al.
Fluids and Barriers of the CNS (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 16

Neurovascular unit, neuroinflammation and neurodegeneration markers in brain disorders
Duraisamy Kempuraj, Kirk D. Dourvetakis, Jessica R. Cohen, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 5

Application of blood-based biomarkers of Alzheimer's disease in clinical practice: Recommendations from Taiwan Dementia Society
Yu‐Wen Cheng, Yen‐Ju Lin, Yung‐Shuan Lin, et al.
Journal of the Formosan Medical Association (2024)
Open Access | Times Cited: 4

Alzheimer's disease blood-based biomarker testing: A stakeholder-informed assessment of coverage considerations
Patricia A. Deverka, Jalayne J. Arias, Grace A. Lin, et al.
Journal of Alzheimer s Disease (2025)
Closed Access

Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer’s disease
Marta Turri, Elisa Conti, Chiara Pavanello, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 10

Tau truncation in the pathogenesis of Alzheimer’s disease: a narrative review
Dandan Chu, Xingyue Yang, Jing Wang, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 6, pp. 1221-1232
Open Access | Times Cited: 10

The Predictive Ability of Blood Neurofilament Light Chain in Predicting Cognitive Decline in the Alzheimer’s Disease Continuum: A Systematic Review and Meta-Analysis
Jianhong Li, Minguang Yang, Ran Wei, et al.
Journal of Alzheimer s Disease (2024) Vol. 97, Iss. 4, pp. 1589-1620
Closed Access | Times Cited: 3

Progress on early diagnosing Alzheimer’s disease
Yixin Chen, Murad Al‐Nusaif, Song Li, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 3, pp. 446-464
Open Access | Times Cited: 3

Tau proteins and senescent Cells: Targeting aging pathways in Alzheimer’s disease
Mahaveer Singh, Haider Ali, S. Renuka Jyothi, et al.
Brain Research (2024) Vol. 1844, pp. 149165-149165
Closed Access | Times Cited: 2

Characterization of Cystatin B Interactome in Saliva from Healthy Elderly and Alzheimer’s Disease Patients
Cristina Contini, Simone Serrao, Barbara Manconi, et al.
Life (2023) Vol. 13, Iss. 3, pp. 748-748
Open Access | Times Cited: 6

Serum amyloid beta 42 levels correlated with metabolic syndrome and its components
Kecheng Li, Xiaoli Zhou, Youren Liu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1

Evaluating the inter-species transmission risk of amyloid beta peptide aggregates via ingestion
J. Dale Raine, Nicholas S. Tolwinski, Jan Gruber, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1

Tetradecyl 2,3-Dihydroxybenzoate Improves Cognitive Function in AD Mice by Modulating Autophagy and Inflammation Through IPA and Hsc70 Targeting
Opeyemi B. Fasina, Lanjie Li, Danni Chen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11719-11719
Open Access | Times Cited: 1

Probing molecular pathways: Illuminating the connection between COVID‐19 and Alzheimer's disease through the endocannabinoid system dynamics
Sun Q, Jinyang Gao, Ran An, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 4
Closed Access

Biomarkers of Alzheimer’s Disease
Ashok Kumar Janakiraman, Hanish Singh Jayasingh Chellammal, Kannan Raman, et al.
(2024), pp. 1-35
Closed Access

Biomarkers of Alzheimer’s Disease
Ashok Kumar Janakiraman, Hanish Singh Jayasingh Chellammal, Kannan Raman, et al.
(2024), pp. 475-509
Closed Access

Neuropsychiatric Symptoms and Blood Biomarkers for Detecting Mild Cognitive Impairment
Yi Jin Leow, Zahinoor Ismail, Seyed Ehsan Saffari, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

The Progression of Current Biomarkers for the Diagnosis of Alzheimer's Disease
Shu Wang
Highlights in Science Engineering and Technology (2023) Vol. 36, pp. 621-627
Open Access | Times Cited: 1

Differential proteomic profile of lumbar and ventricular cerebrospinal fluid
Nina Rostgaard, Markus Harboe Olsen, Maud Eline Ottenheijm, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 2

A Perspective: Challenges in Dementia Research
Mark M. Stecker
Medicina (2022) Vol. 58, Iss. 10, pp. 1368-1368
Open Access | Times Cited: 1

Modern Approaches to the Diagnosis of Cognitive Impairment and Alzheimer’s Disease: A Narrative Literature Review
Aleksandra Ochneva, Kristina Soloveva, Valeria Savenkova, et al.
Consortium Psychiatricum (2023) Vol. 4, Iss. 1, pp. 53-62
Open Access

Evaluating the transmission risk of amyloid beta peptide via ingestion
J. Dale Raine, Nicholas S. Tolwinski, Jan Gruber, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Utility of serum neurofilament light chain and glial fibrillary acidic protein as diagnostic biomarkers of freezing of gait in Parkinson’s disease
Xu Liu, Xuanjing Liu, Yuning Liu, et al.
Brain Research (2023) Vol. 1822, pp. 148660-148660
Closed Access

Page 1

Scroll to top